Kevin Dang

700 total citations
14 papers, 174 citations indexed

About

Kevin Dang is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Kevin Dang has authored 14 papers receiving a total of 174 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in Kevin Dang's work include CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Biosimilars and Bioanalytical Methods (4 papers). Kevin Dang is often cited by papers focused on CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Biosimilars and Bioanalytical Methods (4 papers). Kevin Dang collaborates with scholars based in United States, France and India. Kevin Dang's co-authors include Ute Schellenberger, Wim van Schooten, Duy Pham, Ben Buelow, Nathan D. Trinklein, Starlynn Clarke, Udaya S. Rangaswamy, Katherine E. Harris, Suhasini Iyer and Shelley Force Aldred and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Kevin Dang

12 papers receiving 165 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin Dang United States	6	131	113	62	36	32	14	174
Caleb K. Stein United States	5	67 0.5×	41 0.4×	32 0.5×	55 1.5×	62 1.9×	9	128
Francesca Bonello Italy	9	105 0.8×	28 0.2×	25 0.4×	103 2.9×	143 4.5×	18	181
Bettina Brauchle Germany	4	71 0.5×	30 0.3×	62 1.0×	25 0.7×	29 0.9×	12	107
Xugeng Wang China	4	107 0.8×	15 0.1×	46 0.7×	59 1.6×	64 2.0×	5	141
Yunsi Olyslager United States	8	153 1.2×	21 0.2×	28 0.5×	100 2.8×	108 3.4×	14	180
Lillian Skidmore Italy	5	157 1.2×	133 1.2×	15 0.2×	47 1.3×	4 0.1×	11	192
M. Jevric Serbia	5	48 0.4×	16 0.1×	23 0.4×	40 1.1×	9 0.3×	12	111
Lisa X. Lee United States	5	36 0.3×	16 0.1×	26 0.4×	39 1.1×	21 0.7×	11	96
Nicolas Gourdin France	4	95 0.7×	13 0.1×	99 1.6×	32 0.9×	18 0.6×	6	158
Shakeela Bahadur United States	6	144 1.1×	54 0.5×	54 0.9×	26 0.7×	2 0.1×	8	174

Countries citing papers authored by Kevin Dang

Since Specialization

Citations

This map shows the geographic impact of Kevin Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Dang more than expected).

Fields of papers citing papers by Kevin Dang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Dang. The network helps show where Kevin Dang may publish in the future.

Co-authorship network of co-authors of Kevin Dang

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Dang. A scholar is included among the top collaborators of Kevin Dang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Dang. Kevin Dang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Dalvi, Pranjali, Kevin Dang, James P. Allison, et al.. (2025). Inhibition of CD38 enzyme activity on engrafted human immune cells enhances NAD+ metabolism and inhibits inflammation in an in-vivo model of xeno-GvHD. Frontiers in Immunology. 16. 1640611–1640611.

Dang, Kevin, et al.. (2025). Unmasking Lamotrigine Toxicity: Two Cases with Ocular Red Herrings and the Crucial Role of Vigilant Pharmacological Assessment (P9-11.001). Neurology. 104(7_Supplement_1).

Dang, Kevin, Laure‐Hélène Ouisse, Benjamin Buelow, et al.. (2022). TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity. mAbs. 14(1). 2095949–2095949. 19 indexed citations

Buelow, Ben, Pranjali Dalvi, Kevin Dang, et al.. (2021). TNB585.001: A multicenter, phase 1, open-label, dose-escalation and expansion study of tnb-585, a bispecific T-cell engager targeting PSMA in subjects with metastatic castrate resistant prostate cancer.. Journal of Clinical Oncology. 39(15_suppl). TPS5092–TPS5092. 7 indexed citations

Boudreau, Andrew, Benjamin Buelow, Kevin Dang, et al.. (2021). TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL. mAbs. 13(1). 1890411–1890411. 22 indexed citations

Buelow, Ben, Kevin Dang, Pranjali Dalvi, et al.. (2020). Effect of modulation of CD3 binding in a PSMAxCD3 T-cell engaging bispecific antibody on maintenance of efficient tumor cell kill and cytokine release.. Journal of Clinical Oncology. 38(15_suppl). e17583–e17583. 1 indexed citations

Buelow, Ben, Udaya S. Rangaswamy, Andrew Boudreau, et al.. (2019). TNB-486, a Novel Fully Human Bispecific CD19 x CD3 Antibody That Kills CD19-Positive Tumor Cells with Minimal Cytokine Secretion. Blood. 134(Supplement_1). 4070–4070. 6 indexed citations

Trinklein, Nathan D., Duy Pham, Ute Schellenberger, et al.. (2019). Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies. mAbs. 11(4). 639–652. 82 indexed citations

Clarke, Starlynn, Kevin Dang, Yuping Li, et al.. (2019). A novel CD3xPSMA bispecific antibody for efficient T cell mediated killing of prostate tumor cells with minimal cytokine release.. Journal of Clinical Oncology. 37(7_suppl). 324–324. 2 indexed citations

10.

Buelow, Ben, Starlynn Clarke, Kevin Dang, et al.. (2018). Pre-clinical development of TNB-383B, a fully human T-cell engaging bispecific antibody targeting BCMA for the treatment of multiple myeloma.. Journal of Clinical Oncology. 36(15_suppl). 8034–8034. 19 indexed citations

11.

Rangaswamy, Udaya S., Andrew Boudreau, Ben Buelow, et al.. (2018). A novel T-cell bispecific antibody platform for efficient T-cell mediated killing of tumor cells with minimal cytokine release.. Journal of Clinical Oncology. 36(5_suppl). 209–209. 4 indexed citations

12.

Aldred, Shelley Force, Andrew Boudreau, Ben Buelow, et al.. (2018). Multispecific antibodies targeting CD38 show potent tumor-specific cytotoxicity.. Journal of Clinical Oncology. 36(5_suppl). 57–57. 2 indexed citations

13.

Buelow, Ben, Priya Choudhry, Starlynn Clarke, et al.. (2018). Development of a fully human t-cell engaging bispecific antibody for the treatment of multiple myeloma.. Journal of Clinical Oncology. 36(5_suppl). 60–60. 5 indexed citations

14.

Buelow, Ben, Duy Pham, Starlynn Clarke, et al.. (2017). Development of a fully human T cell engaging bispecific antibody for the treatment of multiple myeloma.. Journal of Clinical Oncology. 35(15_suppl). 8017–8017. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact